These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6334502)

  • 1. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders.
    Buchsbaum MS; DeLisi LE; Holcomb HH; Cappelletti J; King AC; Johnson J; Hazlett E; Dowling-Zimmerman S; Post RM; Morihisa J
    Arch Gen Psychiatry; 1984 Dec; 41(12):1159-66. PubMed ID: 6334502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomographic image measurement in schizophrenia and affective disorders.
    Buchsbaum MS; Cappelletti J; Ball R; Hazlett E; King AC; Johnson J; Wu J; DeLisi LE
    Ann Neurol; 1984; 15 Suppl():S157-65. PubMed ID: 6611116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia.
    Buchsbaum MS; Ingvar DH; Kessler R; Waters RN; Cappelletti J; van Kammen DP; King AC; Johnson JL; Manning RG; Flynn RW; Mann LS; Bunney WE; Sokoloff L
    Arch Gen Psychiatry; 1982 Mar; 39(3):251-9. PubMed ID: 6978119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral metabolic consequences of electrical cutaneous stimulation in normal individuals.
    Buchsbaum MS; Holcomb HH; Johnson J; King AC; Kessler R
    Hum Neurobiol; 1983; 2(1):35-8. PubMed ID: 6603452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography.
    Buchsbaum MS; Nuechterlein KH; Haier RJ; Wu J; Sicotte N; Hazlett E; Asarnow R; Potkin S; Guich S
    Br J Psychiatry; 1990 Feb; 156():216-27. PubMed ID: 2317626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional brain function in schizophrenia. I. A positron emission tomography study.
    Gur RE; Resnick SM; Alavi A; Gur RC; Caroff S; Dann R; Silver FL; Saykin AJ; Chawluk JB; Kushner M
    Arch Gen Psychiatry; 1987 Feb; 44(2):119-25. PubMed ID: 3492982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study.
    Farkas T; Wolf AP; Jaeger J; Brodie JD; Christman DR; Fowler JS
    Arch Gen Psychiatry; 1984 Mar; 41(3):293-300. PubMed ID: 6608333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia.
    Cohen RM; Semple WE; Gross M; Nordahl TE; King AC; Pickar D; Post RM
    Neuropsychopharmacology; 1989 Dec; 2(4):241-54. PubMed ID: 2610821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary data on the metabolic brain pattern of patients with winter seasonal affective disorder.
    Cohen RM; Gross M; Nordahl TE; Semple WE; Oren DA; Rosenthal N
    Arch Gen Psychiatry; 1992 Jul; 49(7):545-52. PubMed ID: 1627045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography.
    Gur RE; Resnick SM; Gur RC; Alavi A; Caroff S; Kushner M; Reivich M
    Arch Gen Psychiatry; 1987 Feb; 44(2):126-9. PubMed ID: 3492983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.
    Buchsbaum MS; Wu J; DeLisi LE; Holcomb H; Kessler R; Johnson J; King AC; Hazlett E; Langston K; Post RM
    J Affect Disord; 1986; 10(2):137-52. PubMed ID: 2941470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [No hypofrontality in schizophrenia demonstrated by positron emission tomography].
    Biver F; Delvenne V; Goldman S; Luxen A; De Maertelaer V; Lotstra F; Mendlewicz J
    Acta Psychiatr Belg; 1992; 92(5):261-78. PubMed ID: 1345405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration.
    Volkow ND; Brodie JD; Wolf AP; Angrist B; Russell J; Cancro R
    J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1199-1202. PubMed ID: 3491182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features.
    Gur RE; Mozley PD; Resnick SM; Mozley LH; Shtasel DL; Gallacher F; Arnold SE; Karp JS; Alavi A; Reivich M
    Arch Gen Psychiatry; 1995 Aug; 52(8):657-67. PubMed ID: 7632119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients.
    DeLisi LE; Buchsbaum MS; Holcomb HH; Dowling-Zimmerman S; Pickar D; Boronow J; Morihisa JM; van Kammen DP; Carpenter W; Kessler R
    Am J Psychiatry; 1985 Jan; 142(1):78-81. PubMed ID: 3871312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose utilization in the temporal cortex of affectively ill patients: positron emission tomography.
    Post RM; DeLisi LE; Holcomb HH; Uhde TW; Cohen R; Buchsbaum MS
    Biol Psychiatry; 1987 May; 22(5):545-53. PubMed ID: 3495297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression.
    Kling AS; Metter EJ; Riege WH; Kuhl DE
    Am J Psychiatry; 1986 Feb; 143(2):175-80. PubMed ID: 3946650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia.
    Szechtman H; Nahmias C; Garnett ES; Firnau G; Brown GM; Kaplan RD; Cleghorn JM
    Arch Gen Psychiatry; 1988 Jun; 45(6):523-32. PubMed ID: 2897836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.
    Baxter LR; Phelps ME; Mazziotta JC; Schwartz JM; Gerner RH; Selin CE; Sumida RM
    Arch Gen Psychiatry; 1985 May; 42(5):441-7. PubMed ID: 3872649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics.
    Buchsbaum MS; Haier RJ; Potkin SG; Nuechterlein K; Bracha HS; Katz M; Lohr J; Wu J; Lottenberg S; Jerabek PA
    Arch Gen Psychiatry; 1992 Dec; 49(12):935-42. PubMed ID: 1360198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.